0001093557-17-000080.txt : 20170315 0001093557-17-000080.hdr.sgml : 20170315 20170315203953 ACCESSION NUMBER: 0001093557-17-000080 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170309 FILED AS OF DATE: 20170315 DATE AS OF CHANGE: 20170315 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DEXCOM INC CENTRAL INDEX KEY: 0001093557 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 330857544 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6340 SEQUENCE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8582000200 MAIL ADDRESS: STREET 1: 6340 SEQUENCE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Leach Jacob Steven CENTRAL INDEX KEY: 0001700255 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51222 FILM NUMBER: 17692704 MAIL ADDRESS: STREET 1: 6340 SEQUENCE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 3 1 edgardoc.xml PRIMARY DOCUMENT X0206 3 2017-03-09 0 0001093557 DEXCOM INC DXCM 0001700255 Leach Jacob Steven 6340 SEQUENCE DRIVE SAN DIEGO CA 92121 0 1 0 0 SVP, Research & Development Common Stock 105933 D Common Stock 12000 I Family Holdings Common Stock 50100 I by Spouse Incentive Stock Option (right to buy) 3.19 2018-12-11 Common Stock 10577 D Incentive Stock Option (right to buy) 5.92 2018-10-02 Common Stock 25000 D Incentive Stock Option (right to buy) 7.27 2019-11-20 Common Stock 4797 D Incentive Stock Option (right to buy) 7.63 2018-05-19 Common Stock 7500 D Incentive Stock Option (right to buy) 9.78 2020-02-18 Common Stock 11458 D Non-Qualified Stock Option (right to buy) 3.19 2018-12-11 Common Stock 1923 D Non-Qualified Stock Option (right to buy) 7.27 2019-11-20 Common Stock 203 D Non-Qualified Stock Option (right to buy) 9.78 2020-02-18 Common Stock 8542 D Included in this number are 57,800 unvested restricted stock units, 23,134 of which were granted on March 8, 2017 and shall vest through March 8, 2020, 21,333 of which were granted on March 8, 2016 shall vest through March 8, 2019 and 13,333 of which were granted on March 8, 2015 and shall vest through March 8, 2018. Shares are held by the Gregg Family Grandchildren's Trust UAD 12/30/2010, with respect to which the reporting person's spouse is a trustee. Shares are held by the Kyndra S. Leach Trust UAD 12/12/2012, with respect to which the reporting person's spouse is a trustee. Shares subject to the option are fully vested and immediately exercisable. CONFIRMING STATEMENT: This Statement confirms that the undersigned Jacob Leach, has authorized and designated Steve Pacelli, Kevin Sun, Patrick Murphy and Timothy O'Brien to execute and file on the undersigned's behalf all Forms 3, 4, and 5 (including any amendments thereto) that the undersigned may be required to file with the U.S. Securities and Exchange Commission as a result of the undersigned's ownership of or transactions in securities of DexCom, Inc. The authority of Steve Pacelli, Kevin Sun, Patrick Murphy and Timothy O'Brien under this Statement shall continue until the undersigned is no longer required to file Forms 3, 4, and 5 with regard to the undersigned's ownership of or transactions in securities of DexCom, Inc., unless earlier revoked in writing. The undersigned acknowledges that Steve Pacelli, Kevin Sun, Patrick Murphy and Timothy O'Brien are not assuming any of the undersigned's responsibilities to comply with Section 16 of the Securities Exchange Act of 1934. Date: March 14, 2017 /s/ JACOB LEACH Jacob Leach By: Timothy O'Brien For: Jacob Leach 2017-03-15